⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Novo Nordisk A/S - share repurchase programme
globenewswire.com
NVO
Spherix Global Insights Finds Specialty Split in Perceptions of Direct-to-Patient Platforms for Obesity Treatment
globenewswire.com
LLY
NVO
Global Perfusion Systems Market to Register Incremental Growth at a CAGR of ~5% by 2034 | DelveInsight
globenewswire.com
MDT
LIVN
BSX
THC
AMGN
AZN
PFE
JNJ
MRNA
BMY
GILD
REGN
TEVA
CL
PG
KO
PEP
DIS
NVDA
GOOG
AMZN
MSFT
AAPL
TSLA
META
CRM
ADBE
NFLX
INTC
AMD
QCOM
CMCSA
T
VZ
IBM
ORCL
CSCO
ACN
HON
GE
BA
CAT
XOM
CVX
JPM
BAC
WFC
C
GS
MS
AXP
V
MA
HD
MCD
SBUX
COST
WMT
TGT
LOW
CVS
UNH
CI
ETSY
ROKU
PYPL
MELI
EBAY
BABA
JD
PDD
NTES
BIDU
TM
SONY
SAP
AIR
ASML
BNTX
NVO
BP
FCX
BHP
RIO
VALE
NKE
LULU
UA
CROX
NOC
GD
LMT
RTX
AVGO
AMAT
LRCX
MU
NXPI
MRVL
SNPS
CDNS
VRTX
BIIB
LLY
ABBV
MRK
CHTR
CMG
SIRI
GEHC
GSK
SNY
MREO
Exert BodySculpt Addresses Rise in Buffalo Hump Cases Linked to GLP-1 Weight Loss Drugs
globenewswire.com
LLY
NVO
The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial
globenewswire.com
LLY
NVO
VKTX
LGVN
Novo Nordisk’s oral semaglutide demonstrates potential to be the first oral GLP-1 RA therapy for children and adolescents with type 2 diabetes
globenewswire.com
NVO
PrecisionBiotics® (Novonesis) and Biocodex Mark Next Phase of Strategic Partnership with New Agreement
prnewswire.com
NVO
New funding opportunities pave the way for better diagnostics and treatment as well as for engineering efficient biosolutions and replacing critical and scarce resources
globenewswire.com
NVO
Connected Drug Delivery Devices Market Insights, Competitive Landscape, and Forecast Report 2025-2032: Rising Demand for Telehealth Programs Integrated with AR and Virtual Reality VR Technologies
globenewswire.com
MDT
WST
MRK
NVO
TNDM
TEVA
BDC
ImmunoForge to Accelerate CNS Drug Development with Innovative BBB Shuttle Platform 'LMT15'
prnewswire.com
NVO